BIOXYTRAN, INC Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Closing Agreement with TRITON FUNDS LP, dated January 15, 2025
BIOXYTRAN, INC
Biotechnology
2025
Extract from Valuation Report of NDPD Pharma, dated October 1, 2024
BIOXYTRAN, INC
Biotechnology
2024
Form of Option Agreement dated June 4, 2021
BIOXYTRAN, INC
Biotechnology
FL
2023
Form of Closing Agreement with TRITON FUNDS LP, dated September 18, 2023
BIOXYTRAN, INC
Biotechnology
CA
2023
Amendment to Closing Agreement with TRITON FUNDS LP, dated August 2, 2023
BIOXYTRAN, INC
Biotechnology
CA
2023
Form of Closing Agreement with Triton Funds LLC, dated June 8, 2023
BIOXYTRAN, INC
Biotechnology
CA
2023
Amendment to engagement letter with WallachBeth Capital LLC, dated May 8, 2023
BIOXYTRAN, INC
Biotechnology
2023
Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022
BIOXYTRAN, INC
Biotechnology
2022
Form of Private Placement Memorandum dated September 17, 2021
BIOXYTRAN, INC
Biotechnology
2021
Form of Private Placement Memorandum dated February 26, 2021
BIOXYTRAN, INC
Biotechnology
2021
Form of Subsidiary Option dated June 4, 2021
BIOXYTRAN, INC
Biotechnology
FL
2021
Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019
BIOXYTRAN, INC
Biotechnology
2019
Form of Agreement of Accord and Satisfaction between U.S. Rare Earth Minerals, Inc., and creditor, dated September 17, 2018
BIOXYTRAN, INC
Biotechnology
NY
2018